author-photo

Michael Tagen

Bristol-Myers Squibb

1

Papers

0

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors.

2021 Dermatologic Therapy
Show All
- Source
- Cite
- Save
Citations (0)